These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1965033

  • 1. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line.
    Nielsen FC, Gammeltoft S, Westermark B, Fahrenkrug J.
    Peptides; 1990; 11(6):1225-31. PubMed ID: 1965033
    [Abstract] [Full Text] [Related]

  • 2. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
    Pozo D, Montilla ML, Guerrero JM, Calvo JR.
    Eur J Pharmacol; 1997 Mar 05; 321(3):379-86. PubMed ID: 9085051
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F, Jürgens H, Winkelmann W, Keck E.
    Cell Signal; 1989 Mar 05; 1(5):435-46. PubMed ID: 2561912
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
    Rodríguez-Pena MS, Guijarro LG, Prieto JC.
    Eur J Pharmacol; 1991 Nov 13; 208(3):207-12. PubMed ID: 1663044
    [Abstract] [Full Text] [Related]

  • 5. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C.
    Am J Physiol; 1991 Feb 13; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [Abstract] [Full Text] [Related]

  • 6. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S, Rattan S.
    J Pharmacol Exp Ther; 1993 Jul 13; 266(1):392-9. PubMed ID: 8392560
    [Abstract] [Full Text] [Related]

  • 7. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
    Dickinson KE, Schachter M, Miles CM, Coy DH, Sever PS.
    Peptides; 1986 Jul 13; 7(5):791-800. PubMed ID: 3025822
    [Abstract] [Full Text] [Related]

  • 8. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P, Waelbroeck M, De Neef P, Tastenoy M, Gourlet P, Cogniaux J, Christophe J.
    FEBS Lett; 1988 Feb 15; 228(2):351-5. PubMed ID: 2830146
    [Abstract] [Full Text] [Related]

  • 9. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Feb 15; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [Abstract] [Full Text] [Related]

  • 10. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
    Waelbroeck M, Robberecht P, Coy DH, Camus JC, De Neef P, Christophe J.
    Endocrinology; 1985 Jun 15; 116(6):2643-9. PubMed ID: 2859987
    [Abstract] [Full Text] [Related]

  • 11. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK, Barnett W, Coy DH, Tougas G, Daniel EE.
    J Pharmacol Exp Ther; 1991 Sep 15; 258(3):986-91. PubMed ID: 1653848
    [Abstract] [Full Text] [Related]

  • 12. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J, Martin JM, el Battari A, Reynier M, Marvaldi J, Pichon J.
    Eur J Biochem; 1989 Mar 15; 180(2):429-33. PubMed ID: 2538330
    [Abstract] [Full Text] [Related]

  • 13. VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form.
    Voisin T, Couvineau A, Guijarro L, Laburthe M.
    Life Sci; 1991 Mar 15; 48(2):135-41. PubMed ID: 1847224
    [Abstract] [Full Text] [Related]

  • 14. Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties.
    Gaudin P, Couvineau A, Maoret JJ, Rouyer-Fessard C, Laburthe M.
    Eur J Pharmacol; 1996 Apr 29; 302(1-3):207-14. PubMed ID: 8791009
    [Abstract] [Full Text] [Related]

  • 15. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 17. Binding of vasoactive intestinal polypeptide to dispersed enterocytes results in rapid removal of the NH2-terminal histidyl residue.
    Nau R, Ballmann M, Conlon JM.
    Mol Cell Endocrinol; 1987 Jul 15; 52(1-2):97-103. PubMed ID: 3040498
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M.
    Am J Physiol; 1993 Feb 15; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of VIP receptors in human lung membranes.
    Robberecht P, Waelbroeck M, de Neef P, Camus JC, Coy DH, Christophe J.
    Peptides; 1988 Feb 15; 9(2):339-45. PubMed ID: 2836826
    [Abstract] [Full Text] [Related]

  • 20. Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini.
    Zhou ZC, Gardner JD, Jensen RT.
    Peptides; 1987 Feb 15; 8(4):633-7. PubMed ID: 2819833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.